Vertex Pharmaceuticals Incorporated
VRTXFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
11,020
Cost of Revenue
1,531
Gross Profit
9,490
Gross Margin
86.1%
Operating Income
-233
Operating Margin
-2.1%
Net Income
-536
Net Margin
-4.9%
EPS (Basic)
$-2.08
EPS (Diluted)
$-2.08
EBITDA
486
EBITDA Margin
4.4%
2023
12/31/2023
Revenue
9,869
Cost of Revenue
1,262
Gross Profit
8,607
Gross Margin
87.2%
Operating Income
3,832
Operating Margin
38.8%
Net Income
3,620
Net Margin
36.7%
EPS (Basic)
$14.05
EPS (Diluted)
$13.89
EBITDA
4,605
EBITDA Margin
46.7%
2022
12/31/2022
Revenue
8,931
Cost of Revenue
1,080
Gross Profit
7,850
Gross Margin
87.9%
Operating Income
4,307
Operating Margin
48.2%
Net Income
3,322
Net Margin
37.2%
EPS (Basic)
$12.97
EPS (Diluted)
$12.82
EBITDA
4,436
EBITDA Margin
49.7%
2021
12/31/2021
Revenue
7,574
Cost of Revenue
904
Gross Profit
6,670
Gross Margin
88.1%
Operating Income
2,782
Operating Margin
36.7%
Net Income
2,342
Net Margin
30.9%
EPS (Basic)
$9.09
EPS (Diluted)
$9.01
EBITDA
2,918
EBITDA Margin
38.5%
2020
12/31/2020
Revenue
6,206
Cost of Revenue
736
Gross Profit
5,469
Gross Margin
88.1%
Operating Income
2,856
Operating Margin
46.0%
Net Income
2,712
Net Margin
43.7%
EPS (Basic)
$10.44
EPS (Diluted)
$10.29
EBITDA
3,284
EBITDA Margin
52.9%